Schedule 13D ownership disclosure

ARMO BioSciences, Inc.

Security class unavailable · CUSIP: 04225U104

Event date: 2018-01-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
4,118,903
Percent of class
14.0700%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000947871-18-000110
Form type
SC 13D
Filer
ARMO BioSciences, Inc.
CIK
CIK 1693664
Filed
Feb 08, 2018
Reporting period
Jan 30, 2018
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub